secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0001493152-24-009536
Event type: debt
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma raises $46,875 via convertible note at 35% discount and 8% interest
--------------------------------------------------------------------------------

- Principal amount $50,000; purchase price $46,875; net proceeds for working capital.
- Conversion price = 65% of lowest closing trade price over prior 10 trading days (35% discount).
- Interest 8% per annum (16% on default); maturity March 1, 2024 (same as issuance date).
- Prepayment rights within 180 days at 110% to 125% premium; no prepayment after 180 days.
- Note issued under Regulation D, unregistered; subject to 4.99% beneficial ownership limitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224009536/0001493152-24-009536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224009536/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer